Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,069 public trials 1,362 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Recruiting

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

NCT06959511

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
Locations
  • Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • University of Virginia Charlottesville, Virginia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

NCT07255404

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Tsinghua Changgung Hospital Beijing, China
  • Sichuan Cancer Hospital Chengdu, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
View all 24 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

NCT06900595

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +16 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Valley Children's Hospital Madera, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View all 77 locations
View Trial Details
Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT06890338

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
  • University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
View all 67 locations
View Trial Details

Related conditions